Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 2c ; Offers Guidance

Avanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $175 million versus the consensus estimate of $165.8 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2025 EPS of $0.75-$0.95, versus the consensus of $0.85. Avanos Medical, Inc. sees FY2025 revenue of $665-685 million, versus the consensus of $672 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c